BRCA‑positive ovarian cancer – case report

06/2020

MUDr. Klaudia Regináčová; doc. MUDr. Martina Kubecová, Ph.D.

Radioterapeutická a onkologická klinika 3. LF UK a FN Královské Vinohrady, Praha

SUMMARY

In our case report we present a patient with BRCA-positive ovarian cancer, who was diagnosed with stage IV and underwent treatment modalities which were accessible. In the case report, we wanted to emphasize the importance of a multidisciplinary team, the need for genetic testing in treatment decisions, as well as the impact of antiangiogenic and targeted treatment on the patienťs survival in a good quality of life.

Key words

ovarian cancer, genetic consultation, surgery, chemotherapy, antiangiogenic treatment, PARP inhibitors, side effects, quality of life